199 related articles for article (PubMed ID: 19221791)
1. Diagnostic accuracy of small breast epithelial mucin mRNA as a marker for bone marrow micrometastasis in breast cancer: a pilot study.
Valladares-Ayerbes M; Iglesias-Díaz P; Díaz-Prado S; Ayude D; Medina V; Haz M; Reboredo M; Antolín S; Calvo L; Antón-Aparicio LM
J Cancer Res Clin Oncol; 2009 Sep; 135(9):1185-95. PubMed ID: 19221791
[TBL] [Abstract][Full Text] [Related]
2. In silico and in vitro analysis of small breast epithelial mucin as a marker for bone marrow micrometastasis in breast cancer.
Ayerbes MV; Díaz-Prado S; Ayude D; Campelo RG; Iglesias P; Haz M; Medina V; Gallegos I; Quindós M; Aparicio LA
Adv Exp Med Biol; 2008; 617():331-9. PubMed ID: 18497056
[TBL] [Abstract][Full Text] [Related]
3. Small breast epithelial mucin (SBEM) has the potential to be a marker for predicting hematogenous micrometastasis and response to neoadjuvant chemotherapy in breast cancer.
Liu ZZ; Xie XD; Qu SX; Zheng ZD; Wang YK
Clin Exp Metastasis; 2010 Apr; 27(4):251-9. PubMed ID: 20364301
[TBL] [Abstract][Full Text] [Related]
4. [Expression of small breast epithelial mucin mRNA in peripheral blood of breast cancer patients and its clinical significance].
Yang HW; Cao J; Yang NW; Liu JL; Zhang CM; Chen JS; Hong JS; Jiang Y; Su JJ
Ai Zheng; 2005 Jul; 24(7):842-5. PubMed ID: 16004812
[TBL] [Abstract][Full Text] [Related]
5. Limitations of reverse-transcriptase polymerase chain reaction analyses for detection of micrometastatic epithelial cancer cells in bone marrow.
Zippelius A; Kufer P; Honold G; Köllermann MW; Oberneder R; Schlimok G; Riethmüller G; Pantel K
J Clin Oncol; 1997 Jul; 15(7):2701-8. PubMed ID: 9215843
[TBL] [Abstract][Full Text] [Related]
6. Real-time RT-PCR correlates with immunocytochemistry for the detection of disseminated epithelial cells in bone marrow aspirates of patients with breast cancer.
Benoy IH; Elst H; Van der Auwera I; Van Laere S; van Dam P; Van Marck E; Scharpé S; Vermeulen PB; Dirix LY
Br J Cancer; 2004 Nov; 91(10):1813-20. PubMed ID: 15505629
[TBL] [Abstract][Full Text] [Related]
7. Bone marrow mammaglobin-1 (SCGB2A2) immunohistochemistry expression as a breast cancer specific marker for early detection of bone marrow micrometastases.
Talaat IM; Hachim MY; Hachim IY; Ibrahim RAE; Ahmed MAER; Tayel HY
Sci Rep; 2020 Aug; 10(1):13061. PubMed ID: 32747636
[TBL] [Abstract][Full Text] [Related]
8. Small breast epithelial mucin tumor tissue expression is associated with increased risk of recurrence and death in triple-negative breast cancer patients.
Liu L; Liu Z; Qu S; Zheng Z; Liu Y; Xie X; Song F
Diagn Pathol; 2013 May; 8():71. PubMed ID: 23635316
[TBL] [Abstract][Full Text] [Related]
9. Comparative analysis between the HER2 status in primary breast cancer tissue and the detection of isolated tumor cells in the bone marrow.
Schindlbeck C; Janni W; Shabani N; Rack B; Gerber B; Schmitt M; Harbeck N; Sommer H; Braun S; Friese K
Breast Cancer Res Treat; 2004 Sep; 87(1):65-74. PubMed ID: 15377852
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of bone marrow micrometastasis detected by nested rt-PCR for keratin-19 in breast cancer patients.
Jung YS; Lee KJ; Kim HJ; Yim HE; Park JS; Soh EY; Kim MW; Park HB
Jpn J Clin Oncol; 2003 Apr; 33(4):167-72. PubMed ID: 12810830
[TBL] [Abstract][Full Text] [Related]
11. [Detection of disseminated carcinoma cells in bone marrow and peripheral blood in primary breast cancer with RT/PCR of parathyroid hormone-related protein (PTHrP)].
Liersch T; Gatzemeier W; Scharnberg P; Jürgens B; Wörmann B; Becker H; Rauschecker HF; Hiddemann W; Wulf GG
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):277-80. PubMed ID: 14518259
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of breast tumour cell contamination in the bone marrow and leukapheresis collections by RT-PCR for cytokeratin-19 mRNA.
Vannucchi AM; Bosi A; Glinz S; Pacini P; Linari S; Saccardi R; Alterini R; Rigacci L; Guidi S; Lombardini L; Longo G; Mariani MP; Rossi-Ferrini P
Br J Haematol; 1998 Dec; 103(3):610-7. PubMed ID: 9858208
[TBL] [Abstract][Full Text] [Related]
13. Expression of small breast epithelial mucin (SBEM) protein in tissue microarrays (TMAs) of primary invasive breast cancers.
Skliris GP; Hubé F; Gheorghiu I; Mutawe MM; Penner C; Watson PH; Murphy LC; Leygue E; Myal Y
Histopathology; 2008 Feb; 52(3):355-69. PubMed ID: 18269587
[TBL] [Abstract][Full Text] [Related]
14. Disseminated tumor cells in bone marrow assessed by TWIST1, cytokeratin 19, and mammaglobin A mRNA predict clinical outcome in operable breast cancer patients.
Tjensvoll K; Oltedal S; Farmen RK; Shammas FV; Heikkilä R; Kvaløy JT; Gilje B; Smaaland R; Nordgård O
Clin Breast Cancer; 2010 Oct; 10(5):378-84. PubMed ID: 20920982
[TBL] [Abstract][Full Text] [Related]
15. Her2 expression on disseminated tumor cells from bone marrow of breast cancer patients.
Becker S; Becker-Pergola G; Fehm T; Wallwiener D; Solomayer EF
Anticancer Res; 2005; 25(3B):2171-5. PubMed ID: 16158960
[TBL] [Abstract][Full Text] [Related]
16. Evaluating GA733-2 mRNA as a marker for the detection of micrometastatic breast cancer in peripheral blood and bone marrow.
Zhong XY; Kaul S; Eichler A; Bastert G
Arch Gynecol Obstet; 1999 Nov; 263(1-2):2-6. PubMed ID: 10728619
[TBL] [Abstract][Full Text] [Related]
17. Detection of disseminated tumor cells in the bone marrow of breast cancer patients using multiplex gene expression measurements identifies new therapeutic targets in patients at high risk for the development of metastatic disease.
Siddappa CM; Watson MA; Pillai SG; Trinkaus K; Fleming T; Aft R
Breast Cancer Res Treat; 2013 Jan; 137(1):45-56. PubMed ID: 23129172
[TBL] [Abstract][Full Text] [Related]
18. The detection of breast carcinoma micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction.
Noguchi S; Aihara T; Nakamori S; Motomura K; Inaji H; Imaoka S; Koyama H
Cancer; 1994 Sep; 74(5):1595-600. PubMed ID: 7520351
[TBL] [Abstract][Full Text] [Related]
19. HER2 status of bone marrow micrometastasis and their corresponding primary tumours in a pilot study of 27 cases: a possible tool for anti-HER2 therapy management?
Vincent-Salomon A; Pierga JY; Couturier J; d'Enghien CD; Nos C; Sigal-Zafrani B; Lae M; Fréneaux P; Diéras V; Thiéry JP; Sastre-Garau X
Br J Cancer; 2007 Feb; 96(4):654-9. PubMed ID: 17262082
[TBL] [Abstract][Full Text] [Related]
20. A small subgroup of operable breast cancer patients with poor prognosis identified by quantitative real-time RT-PCR detection of mammaglobin A and trefoil factor 1 mRNA expression in bone marrow.
Tjensvoll K; Gilje B; Oltedal S; Shammas VF; Kvaløy JT; Heikkilä R; Nordgård O
Breast Cancer Res Treat; 2009 Jul; 116(2):329-38. PubMed ID: 18846421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
